Literature DB >> 21582127

2-Chloro-quinoxaline.

Seik Weng Ng1.   

Abstract

In the title compound, C(8)H(5)ClN(2), the planar mol-ecules are arranged with their Cl atoms in close contact [Cl⋯Cl = 3.808 (1) and 3.881 (1) Å], indicating weak Cl⋯Cl inter-actions, which give rise to a supra-molecular chain.

Entities:  

Year:  2009        PMID: 21582127      PMCID: PMC2968544          DOI: 10.1107/S1600536809003717

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

The title compound is a reagent in the synthesis of chloro­quinoxaline sulfamide, which is active against human cancers. For the synthesis of other phamaceutically active derivatives through conventional and other synthetic routes, see: Bhattacharjee et al. (2008 ▶); Cuenca et al. (2008 ▶); Hassan et al. (2006 ▶); Rangisetty et al. (2001 ▶); Rizzo et al. (2002 ▶); Sugimoto et al. (2003 ▶).

Experimental

Crystal data

C8H5ClN2 M = 164.59 Monoclinic, a = 9.1299 (2) Å b = 3.8082 (1) Å c = 21.0777 (6) Å β = 93.028 (2)° V = 731.82 (3) Å3 Z = 4 Mo Kα radiation μ = 0.44 mm−1 T = 118 (2) K 0.20 × 0.06 × 0.02 mm

Data collection

Bruker SMART APEX diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 1996 ▶) T min = 0.916, T max = 0.991 6145 measured reflections 1659 independent reflections 1173 reflections with I > 2σ(I) R int = 0.048

Refinement

R[F 2 > 2σ(F 2)] = 0.038 wR(F 2) = 0.099 S = 1.03 1659 reflections 100 parameters H-atom parameters constrained Δρmax = 0.29 e Å−3 Δρmin = −0.30 e Å−3 Data collection: APEX2 (Bruker, 2008 ▶); cell refinement: SAINT (Bruker, 2008 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: X-SEED (Barbour, 2001 ▶); software used to prepare material for publication: publCIF (Westrip, 2009 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536809003717/tk2366sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809003717/tk2366Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C8H5ClN2F(000) = 336
Mr = 164.59Dx = 1.494 Mg m3
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ynCell parameters from 1328 reflections
a = 9.1299 (2) Åθ = 2.4–28.1°
b = 3.8082 (1) ŵ = 0.44 mm1
c = 21.0777 (6) ÅT = 118 K
β = 93.028 (2)°Prism, colorless
V = 731.82 (3) Å30.20 × 0.06 × 0.02 mm
Z = 4
Bruker SMART APEX diffractometer1659 independent reflections
Radiation source: fine-focus sealed tube1173 reflections with I > 2σ(I)
graphiteRint = 0.048
ω scansθmax = 27.5°, θmin = 1.9°
Absorption correction: multi-scan (SADABS; Sheldrick, 1996)h = −11→11
Tmin = 0.916, Tmax = 0.991k = −4→4
6145 measured reflectionsl = −27→27
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.038Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.099H-atom parameters constrained
S = 1.03w = 1/[σ2(Fo2) + (0.0465P)2 + 0.1632P] where P = (Fo2 + 2Fc2)/3
1659 reflections(Δ/σ)max = 0.001
100 parametersΔρmax = 0.29 e Å3
0 restraintsΔρmin = −0.30 e Å3
xyzUiso*/Ueq
Cl10.60849 (6)0.47749 (15)0.58158 (3)0.03308 (19)
N10.88157 (18)0.6668 (4)0.57567 (8)0.0202 (4)
N20.8977 (2)0.9189 (4)0.70202 (8)0.0248 (4)
C10.7733 (2)0.6552 (5)0.61274 (10)0.0219 (5)
C20.7783 (2)0.7779 (6)0.67617 (10)0.0261 (5)
H20.69380.75750.70030.031*
C31.0163 (2)0.9407 (5)0.66453 (9)0.0194 (4)
C41.1478 (2)1.0934 (5)0.68919 (10)0.0231 (5)
H41.15401.18160.73140.028*
C51.2662 (2)1.1150 (5)0.65264 (10)0.0250 (5)
H51.35491.21650.66960.030*
C61.2576 (2)0.9872 (5)0.58970 (10)0.0254 (5)
H61.34081.00490.56460.030*
C71.1318 (2)0.8385 (5)0.56422 (10)0.0214 (4)
H71.12750.75280.52180.026*
C81.0086 (2)0.8132 (5)0.60139 (9)0.0179 (4)
U11U22U33U12U13U23
Cl10.0215 (3)0.0305 (3)0.0466 (4)−0.0056 (2)−0.0042 (2)0.0009 (3)
N10.0187 (9)0.0178 (8)0.0239 (9)0.0000 (7)−0.0020 (7)0.0008 (7)
N20.0286 (10)0.0243 (9)0.0219 (9)0.0009 (8)0.0049 (8)0.0013 (7)
C10.0190 (10)0.0185 (10)0.0277 (11)−0.0005 (8)−0.0029 (9)0.0043 (9)
C20.0252 (12)0.0257 (11)0.0278 (12)0.0006 (9)0.0067 (9)0.0018 (10)
C30.0234 (10)0.0148 (9)0.0200 (10)0.0022 (8)0.0005 (8)0.0027 (8)
C40.0316 (12)0.0177 (10)0.0194 (11)−0.0007 (8)−0.0047 (9)−0.0008 (8)
C50.0247 (11)0.0198 (10)0.0296 (12)−0.0018 (8)−0.0066 (9)0.0028 (9)
C60.0222 (11)0.0232 (11)0.0310 (12)−0.0007 (9)0.0032 (9)0.0045 (10)
C70.0256 (11)0.0192 (10)0.0195 (10)0.0028 (9)0.0019 (8)0.0000 (9)
C80.0188 (10)0.0144 (9)0.0201 (10)0.0014 (8)−0.0031 (8)0.0028 (8)
Cl1—C11.746 (2)C4—C51.363 (3)
N1—C11.293 (3)C4—H40.9500
N1—C81.372 (2)C5—C61.411 (3)
N2—C21.308 (3)C5—H50.9500
N2—C31.376 (3)C6—C71.365 (3)
C1—C21.415 (3)C6—H60.9500
C2—H20.9500C7—C81.408 (3)
C3—C41.409 (3)C7—H70.9500
C3—C81.415 (3)
C1—N1—C8115.61 (17)C3—C4—H4119.9
C2—N2—C3116.68 (18)C4—C5—C6120.3 (2)
N1—C1—C2124.93 (19)C4—C5—H5119.9
N1—C1—Cl1117.21 (16)C6—C5—H5119.9
C2—C1—Cl1117.87 (16)C7—C6—C5121.13 (19)
N2—C2—C1120.92 (19)C7—C6—H6119.4
N2—C2—H2119.5C5—C6—H6119.4
C1—C2—H2119.5C6—C7—C8119.33 (19)
N2—C3—C4119.62 (18)C6—C7—H7120.3
N2—C3—C8121.21 (18)C8—C7—H7120.3
C4—C3—C8119.18 (18)N1—C8—C7119.43 (18)
C5—C4—C3120.18 (19)N1—C8—C3120.65 (18)
C5—C4—H4119.9C7—C8—C3119.91 (18)
C8—N1—C1—C2−0.5 (3)C4—C5—C6—C7−0.3 (3)
C8—N1—C1—Cl1178.97 (14)C5—C6—C7—C80.2 (3)
C3—N2—C2—C10.0 (3)C1—N1—C8—C7−179.61 (18)
N1—C1—C2—N20.6 (3)C1—N1—C8—C30.0 (3)
Cl1—C1—C2—N2−178.91 (16)C6—C7—C8—N1179.40 (18)
C2—N2—C3—C4179.27 (19)C6—C7—C8—C3−0.2 (3)
C2—N2—C3—C8−0.5 (3)N2—C3—C8—N10.6 (3)
N2—C3—C4—C5179.69 (18)C4—C3—C8—N1−179.22 (18)
C8—C3—C4—C5−0.5 (3)N2—C3—C8—C7−179.87 (17)
C3—C4—C5—C60.5 (3)C4—C3—C8—C70.3 (3)
  4 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Synthesis of new arylaminoquinoxalines and their antimalarial activity in mice.

Authors:  J B Rangisetty; C N Gupta; A L Prasad; P Srinivas; N Sridhar; P Parimoo; A Veeranjaneyulu
Journal:  J Pharm Pharmacol       Date:  2001-10       Impact factor: 3.765

3.  Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.

Authors:  Seham Y Hassan; Sherine N Khattab; Adnan A Bekhit; Adel Amer
Journal:  Bioorg Med Chem Lett       Date:  2005-12-13       Impact factor: 2.823

4.  Preparation of nitrogen-containing pi-deficient heteroaromatic Grignard reagents: oxidative magnesiation of nitrogen-containing pi-deficient halogenoheteroaromatics using active magnesium.

Authors:  Osamu Sugimoto; Shigeru Yamada; Ken-ichi Tanji
Journal:  J Org Chem       Date:  2003-03-07       Impact factor: 4.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.